Peters L J
Br J Cancer. 1975 Sep;32(3):355-65. doi: 10.1038/bjc.1975.235.
An experimental tumour system for the study of metastasis has been developed using a syngeneically transplanted murine squamous carcinoma of spontaneous origin. Implants of the tumour, which does not elicit a significant immune response, grew and metastasized regularly to regional lymph nodes and lungs, in a manner comparable with that of the more malignant types of human epithelioma. The system has been used to test the influece of pre-operative irradiation, regional lymph node excision, tumour biopsy and manipulation, on metastasis. Of these, only pre-operative irradiation with 2000 rad 24 h before tumour excision produced a significant differential effect--a lower incidence of metastasis. By contrast, local radiation therapy sufficient to cause complete tumour regression but insufficient to achieve long-term local cure was shown to result in accelerated metastasis. A highly significant inhibition of metastasis was observed with the drug ICRF 159, but histological features suggested that its anti-metastatic effect in this system did not depend on morphological changes which might prevent dissemination of tumour cells.
利用一种自发产生的同基因移植小鼠鳞状细胞癌,开发了一种用于研究转移的实验性肿瘤系统。该肿瘤植入物不会引发显著的免疫反应,它会以与人类上皮瘤中更恶性类型相当的方式,定期生长并转移至局部淋巴结和肺部。该系统已被用于测试术前放疗、局部淋巴结切除、肿瘤活检及操作对转移的影响。其中,只有在肿瘤切除前24小时进行2000拉德的术前放疗产生了显著的差异效应——转移发生率降低。相比之下,足以导致肿瘤完全消退但不足以实现长期局部治愈的局部放射治疗被证明会导致转移加速。使用药物ICRF 159观察到对转移有高度显著的抑制作用,但组织学特征表明,其在该系统中的抗转移作用并不依赖于可能阻止肿瘤细胞扩散的形态学变化。